|
The problem… Substance Dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly.
| |
Pervasive: 10.5% prevalence (1.93% incidence in past 12 months) |
| |
Untreated: Up to 72% do not have claims for Substance Dependence treatment |
| |
Costly: $160MM total claims per 1MM members |
| |
» |
High utilizing Substance Dependence members are 700% more costly than
non
Substance Dependence members |
| |
Chronic Conditions |
| |
» |
Substance Dependence increases cost of chronic conditions between 75-400% |
We shift the paradigm… Most existing Substance Dependence treatment approaches focus on a specific medical intervention, or provide various types of counseling without coordination between medical and behavioral components. These fragmented and siloed methods do not provide optimal care. Catasys bridges these gaps in the treatment continuum by addressing substance dependence as a chronic disease, taking a holistic approach, and focusing on translating science into clinical practice.
OnTrak is integrated… We provide an innovative, proprietary and integrated substance dependence treatment program that combines medical interventions, psychosocial therapy and care coaching into a comprehensive, long-term treatment solution.
OnTrak works… We use the latest in evidence-based methodology to improve member care and to reduce costs for Payors. OnTrak has demonstrated reductions in drug cravings, drug use and health
care costs.
|
